ID   CHS-6
AC   CVCL_L319
SY   Canine Histiocytic Sarcoma-6
DR   Wikidata; Q54813308
RX   PubMed=17213706;
RX   PubMed=30268330;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Bernese mountain dog; VBO=VBO_0200161.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 16
//
RX   PubMed=17213706; DOI=10.1292/jvms.68.1343;
RA   Azakami D., Bonkobara M., Washizu T., Iida A., Kondo M., Kato R.,
RA   Niikura Y., Iwaki S., Tamahara S., Matsuki N., Ono K.;
RT   "Establishment and biological characterization of canine histiocytic
RT   sarcoma cell lines.";
RL   J. Vet. Med. Sci. 68:1343-1346(2006).
//
RX   PubMed=30268330; DOI=10.1016/j.tvjl.2018.09.001;
RA   Miyamoto R., Kurita S., Tani H., Ikeda T., Ishizaka M., Saima H.,
RA   Kobayashi M., Tamura K., Bonkobara M.;
RT   "Canine squamous cell carcinoma cell lines with high expression of
RT   survivin are sensitive to survivin inhibitor YM155.";
RL   Vet. J. 240:31-36(2018).
//